General Hospital Psychiatry
Volume 25, Issue 1 , Pages 39-45 , January 2003

Acute-phase treatment in general hospitals: clinical psychopharmacologic evaluation in first-episode schizophrenia patients

  • Kotaro Hatta, M.D., Ph.D.

      Affiliations

    • Department of Psychiatry, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-3-5802-1071; fax: +81-3-5802-1071.
    • ,
  • Hiroyuki Nakamura, M.D., Ph.D.

      Affiliations

    • Department of Public Health, Kanazawa University School of Medicine, Kanazawa, Japan
    • ,
  • Ichiyo Matsuzaki, M.D., Ph.D.

      Affiliations

    • Institute of Community Medicine, University of Tsukuba, Tsukuba, Japan

References 

  1. Currier GW, Allen MH. Emergency psychiatry (physical and chemical restraint in the psychiatric emergency service). Psychiatr Serv. 2000;51:717–719
  2. Hatta K, Takahashi T, Nakamura H, et al.  Laboratory findings in acute schizophrenia (relevance to medical management on emergency admission). Gen Hosp Psychiatry. 1999;21:220–227
  3. Hatta K, Takahashi T, Nakamura H, et al.  Hypokalemia and agitation in acute psychotic patients. Psychiatry Res. 1999;86:85–88
  4. Hatta K, Takahashi T, Nakamura H, Yamashiro H, Yonezawa Y. Prolonged QT interval in acute psychotic patients. Psychiatry Res. 2000;94:279–285
  5. Hatta K, Takahashi T, Nakamura H, et al.  A risk for obstruction of the airways in the parenteral use of levomepromazine with benzodiazepine. Pharmacopsychiatry. 1998;31:126–130
  6. Hatta K, Takahashi T, Nakamura H, et al.  Prolonged upper airway instability in parenteral use of benzodiazepine with levomepromazine. J Clin Psychopharmacology. 2000;20:99–101
  7. Hatta K, Takahashi T, Nakamura H, et al.  The association between intravenous haloperidol and prolonged QT interval. J Clin Psychopharmacology. 2001;21:257–261
  8. Kaplan HI, Sadock BJ. Synopsis of Psychiatry. 8th Ed.. Baltimore: Lippincott, Williams, & Wilkins; 1998;
  9. Lieberman J, Jody D, Geisler S, et al.  Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry. 1993;50:369–376
  10. Levinson DF, Singh H, Simpson GM. Timing of acute clinical response to fluphenazine. Br J Psychiatry. 1992;160:365–371
  11. Lieberman J, Alvir J, Woerner M, et al.  Prospective study of psychobiology in first episode schizophrenia at Hillside Hospital (design, methodology, and summary of findings). Schizophr Bull. 1992;18:351–371
  12. Lieberman JA, Alvir JM, Koreen A, et al.  Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology. 1996;14:13S–21S
  13. Kinon BJ, Kane JM, Chakos M, Munne R. Possible predictors of neuroleptic-resistant schizophrenic relapse (influence of negative symptoms and acute extrapyramidal side effects). Psychopharmacol Bull. 1993;29:365–369
  14. World Health Organization . The ICD-10 Classification of Mental and Behavioural Disorders (Clinical Descriptions and Diagnostic Guidelines). Geneva: WHO; 1992;
  15. Key SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Rating Manual. Toronto: Multi-Health System Inc; 1991;
  16. Van Os J, Fahy TA, Jones P, et al.  Psychopathological syndromes in the functional psychoses (associations with course and outcome). Psychol Med. 1996;26:161–176
  17. Smith TE, Hull JW, Goodman M, et al.  The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder. J Nerv Ment Dis. 1999;187:102–108
  18. Baldessarini RJ. Chemotherapy in Psychiatry. Cambridge: Harvard University Press; 1985;
  19. Osser DN, Patterson RD. Pharmacotherapy of schizophrenia 1 (acute treatment). In:  Soreff SM editors. Handbook for the treatment of the seriously mentally ill. Seattle: Hogrefe & Huber; 1996;p. 91–119
  20. Marder SR. Management of treatment-resistant patients with schizophrenia. J Clin Psychiatry. 1996;57(Suppl 11):26–30
  21. Meltzer HY. Treatment of the neuroleptic-nonresponsive schizophrenic patient. Schizophrenia Bull. 1992;18:515–542

PII: S0163-8343(02)00252-9

doi: 10.1016/S0163-8343(02)00252-9

General Hospital Psychiatry
Volume 25, Issue 1 , Pages 39-45 , January 2003

Article Tools

* Image Usage & Resolution